# Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

> **NCT04528927** · PHASE3 · WITHDRAWN · sponsor: **Abderrahmane Mami Hospital**

## Conditions studied

- COVID 19
- Patients Hospitalized

## Interventions

- **DRUG:** HCQ
- **DRUG:** Azithromycin
- **DRUG:** Doxycycline
- **DIETARY_SUPPLEMENT:** Zinc

## Key facts

- **NCT ID:** NCT04528927
- **Lead sponsor:** Abderrahmane Mami Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-15
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** \- Interest in the use of HCQ is controversial.
- **Last updated:** 2020-08-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528927, "Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04528927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*